Abstract
Poor attention control has been implicated in the development of anxiety and depression-related disorders and it is a key diagnostic criterion. This study aims to understand the possible neural mechanisms behind this.
191 German participants aged 20-80 were assessed on their level of attention control, depression and anxiety as part of the Leipzig Study for Mind-Body-Emotion Interactions. Network-based statistics were applied to their resting-state functional connectivity (rsFC) data to identify networks positively and negatively associated with attention control. Mediation analyses were then performed with these two networks as mediators.
Attention control correlated negatively with both anxiety and depression. The frontoparietal- or dorsal attention-somatomotor connections featured prominently in the attention control-positive network (ACPN). This network correlated positively with attention control, and negatively with both anxiety and depression. The attention control-negative network (ACNN) was largely represented by the ventral attention- or dorsal attention-visual connections. The ACPN was a significant and partial mediator between attention control and anxiety and a complete mediator for the relationship between attention control and depression. These findings could prove useful as neuroeducation in anxiety- and depression-related disorders, and as evidence for attention-based therapy.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Datasets from the Leipzig Study for Mind-Body-Emotion Interactions project and an additional follow-up project were used in this study. The study protocol was approved by the University of Leipzig's medical faculty's ethics committee (reference number 097/15-ff).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
This work is supported by funding from the Nanyang Assistant Professorship (Award no. 021080-00001)
Data Availability
Data was not collected firsthand. The open-access anonymous database utilised in our study may be accessed via Babayan et al., 2019 and Mendes et al., 2019.
http://fcon_1000.projects.nitrc.org/indi/retro/MPI_LEMON.html.
